97.60EUR+1.14%Mkt Cap: 1.67B EURP/E: 20.84Last update: 2026-05-14
Pharma Mar, S.A., a biopharmaceutical company, focuses on the research, development, production, and commercialization of bio-active principles for the use in oncology in Spain, Germany, Ireland, France, Switzerland, res…
Industry Peers
Biotechnologyloading…
Indicators:|
Key Statistics
Valuation
P/E (Trailing)20.84
P/E (Forward)13.04
PEG0.31
P/B6.64
P/S7.39
EV/EBITDA22.08
EV/Revenue6.88
EPS (TTM)4.61
EPS (Forward)7.38
Cash Flow & Leverage
FCF Yield2.10%
FCF Margin15.56%
Operating CF53.13M EUR
CapEx (TTM)9.38M EUR
Net Debt/EBITDA-1.71
Net Debt-120.32M EUR
Technical
SMA 5091.35 (+6.8%)
SMA 20082.65 (+18.1%)
Beta0.37
S&P 52W Chg24.23%
Avg Vol (30d)77.68K
Avg Vol (10d)80.57K
Technical Indicators
RSI (14)53.5
MACD2.1540
MACD Signal2.8606
MACD Hist.-0.7066
BB Upper103.84 EUR
BB Middle97.93 EUR
BB Lower92.02 EUR
BB Width12.08%
ATR (14)3.550 EUR
Vol Ratio (20d)0.38x
52W Range
70.1078% of range105.20
52W High105.20 EUR
52W Low70.10 EUR
Profitability
Gross Margin94.46%
EBITDA Margin31.17%
Profit Margin33.87%
Oper. Margin1.45%
ROE29.78%
ROA18.98%
Revenue Growth10.40%
Earnings Growth—
Balance Sheet
Debt/Equity0.20
Current Ratio3.06
Quick Ratio2.33
Book Value/Sh14.51 EUR
Cash/Share9.669 EUR
Dividends
Fwd Div Rate0.8000 EUR
Trail. Div Rate0.0000 EUR
Div. Yield0.83%
5Y Avg Yield—
Payout Ratio17.34%
Ex-Div DateJun 25, 2025
Pay Date—
Splits
Last Split1:12
Split DateJul 22, 2020
Ownership
Shares Out.17.31M
Float13.43M
Insiders29.74%
Institutions8.32%
Analyst Consensus
Rating1.6 (Buy)
Target (Mean)108.89 EUR
Target Range75.00 EUR – 125.00 EUR
# Analysts9
Company
Market Cap1.67B EUR
Enterprise Value1.55B EUR
Revenue (TTM)225.43M EUR
Gross Profit209.13M EUR
Net Income (TTM)74.99M EUR
Revenue/Share12.98 EUR
Fiscal Year EndDec 2025
MR QuarterMar 2026
Employees505
Last Price97.60 EUR
CountryES
SectorHealthcare
IndustryBiotechnology
ISINES0169501022